Back    Zoom +    Zoom -
WUXI APPTEC Rallies 8%; Broker Cites Mgmt Saying New Output Increase Requires Only 2 Mths
Recommend
7
Positive
7
Negative
5
WUXI APPTEC (02359.HK) opened 1.1% higher this morning, with gains gradually expanding. The stock rallied nearly 8.4% to a high of $119 after midday, with a turnover of $958 million.

HSBC Global Research issued a research report after attending WUXI APPTEC's investor open day at its Changzhou production base.

Related NewsJPM Continues to Name WUXI APPTEC as CXO Top Pick w/ Rating Kept Overweight
The Company said that its output expansion is progressing as planned to support revenue growth. WUXI APPTEC's TIDES business capacity expansion is on track to reach over 100,000 liters in 2025. The Company forecasted production of 58,000 kilograms of peptides and oligonucleotides in 2025.

WUXI APPTEC highlighted its optimized operational strategy during its investor open day, the broker added.

The time required for new output enhancement is only 2 months, compared to approx. 2 years in 2017, mainly due to: 1) scale effects, more experienced staff, and a complete training system, 2) full implementation of digital system, increasing equipment (reactors) utilization from 60% to 72%, driving revenue growth rather than simply expanding capacities, 3) solid quality system, with no negative findings in this year's FDA audits.

Related NewsBofAS Raises Earnings Forecasts for WUXI APPTEC w/ TP Lifted to HKD130.7
Therefore, HSBC Global Research kept rating at Buy for WUXI APPTEC's H-shares, with a target price of $124.
AASTOCKS Financial News
Website: www.aastocks.com